Cancer Diagnosis News and Research

RSS

BUSM to develop novel technologies for early lung cancer detection

Boston University School of Medicine (BUSM) is the lead institution on a $13.6 million study aimed at developing novel technologies for the early detection of lung cancer.

20 Oct 2011

Many cancer survivors continue to have poorer health years after completion of treatment

Forty-five per cent of cancer survivors in Northern Ireland suffer from physical and mental health problems years after their treatment has finished, according to new research from Macmillan Cancer Support and Queen's University Belfast.

11 Oct 2011

Case Western Reserve wins NCI grant to study genetic determinants of esophageal cancer

Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center are proud to announce the receipt of a highly competitive $5.4 million grant to study genetic determinants of Barrett's esophagus and esophageal adenocarcinoma.

11 Oct 2011

UNC professor to co-direct Barrett's Esophagus Translational Research Network projects

A University of North Carolina at Chapel Hill researcher is one of five co-principal investigators in a new collaborative network created to study genetic determinants of Barrett's esophagus and esophageal adenocarcinoma.

10 Oct 2011

Not enough doctors in Australia to follow up on breast cancer cases

Australian women who have undergone surgery for early-stage breast cancer could be monitored afterwards by their GP instead of a hospital clinic, under a federal government project that acknowledges there will not be enough specialist doctors for the coming wave of cancer cases among ageing baby boomers.

26 Sep 2011

Genetic testing for breast and ovarian cancer

Experts from Cancer Treatment Centers of America (CTCA) provide some clues as to who should be using these tests. They explain that women who have been diagnosed with cancer and/or people who have a strong family history of cancer can consider genetic testing. Red flags to consider are anyone in the family who developed cancer at a young age, multiple family members who developed cancer, if a person experienced bilateral cancer (cancer in both breasts), breast and ovarian cancer in the same woman, or cancer appeared where it wasn’t expected (like breast cancer in men)

26 Sep 2011

Sanofi-aventis sponsors People vs. Cancer initiative

Sanofi-aventis Canada is proud to be the national sponsor of People vs. Cancer, a speaking tour of three Canadian universities featuring Stephen Lewis, former Canadian Ambassador to the United Nations and United Nations Special Envoy for HIV/AIDS in Africa.

22 Sep 2011

Peptide receptor radiolabeled therapy shows promise against neuroendocrine tumors

According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate), is effective not only in decreasing tumor size but also in reducing the severity of side effects that often accompany a cancer diagnosis.

22 Sep 2011

NTNU genetic research shows best recipe to limit risk of lifestyle-related diseases

What should we eat? Answers abound in the international media, all of which rely on their interpretation of recent medical literature to come up with recommendations for the healthiest diet. But what if you could answer this question at a molecular level - what if you could find out how our genes respond to the foods we eat, and what this does to the cellular processes that make us healthy - or not? That's precisely what biologists at the Norwegian University of Science and Technology have done.

19 Sep 2011

New GE healthymagination initiative aims to improve cancer innovation and care

GE and leading healthcare and financial partners today launched a new healthymagination initiative aimed at accelerating cancer innovation and improving care for 10 million cancer patients around the world by 2020.

16 Sep 2011

Spanish research establishes factors associated with tiredness in breast cancer survivors

In Spain, 5-year survival following breast cancer diagnosis is more than 83%. Around 66% suffer fatigue following treatment. A Spanish research establishes the factors associated with tiredness in cancer survivors to improve their quality of life and rehabilitation.

15 Sep 2011

Web-based tool can improve employment outcomes of breast cancer survivors

In a paper to be presented at the upcoming HFES 55th Annual Meeting in Las Vegas, Nevada, human factors/ergonomics researchers will describe WISE, a Web-based tool for breast cancer survivors designed to reduce work disabilities and improve employment outcomes.

14 Sep 2011

Women with BRCA gene mutations at risk of developing cancers at earlier ages

A new analysis has found that women who develop certain hereditary cancers develop them at earlier ages than women in the previous generation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the results point to the importance of tracking younger ages of cancer diagnosis to determine when to provide counseling, screening, and treatment services.

12 Sep 2011

New studies on breast cancer screening, treatment and survival

New studies on breast cancer screening, treatment, and survival were released today in advance of the 2011 Breast Cancer Symposium. The symposium is being held September 8-10, 2011, at the San Francisco Marriott Marquis in San Francisco.

8 Sep 2011

Studies examine overuse of scans in determining status of prostate cancer

During Prostate Cancer Awareness Month, researchers will publish the findings of two studies examining the use, or overuse, of scans in determining the status or level of a patient's prostate cancer after diagnosis. "Typically, patients with an elevated PSA level undergo a prostate biopsy to confirm the presence of cancer.

8 Sep 2011

First Edition: September 7, 2011

"Publicly, consumer and patient advocates continue to cheer wildly for last year's health care law. Behind the scenes, however, some worry that they are losing a few key battles to the insurance and business communities.

7 Sep 2011

Combination of blood tests and ROMA algorithm receives FDA clearance to treat ovarian cancer

Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass.

7 Sep 2011

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

7 Sep 2011

Low-cost, portable technique can detect specific proteins in human blood

Blood tests are important diagnostic tools. They accurately tease-out vanishingly small concentrations of proteins and other molecules that help give a picture of overall health or signal the presence of specific diseases. Current testing procedures, however, are expensive and time-consuming, while sophisticated test equipment is bulky and difficult to transport.

2 Sep 2011

9/11 firefighters at greater risk of cancer

A new study shows that firefighters who were exposed to toxic dust and fumes clogging the air after the World Trade Center towers collapsed 10 years ago are more likely to develop cancer.

2 Sep 2011

Cancer Diagnosis News and Research

BUSM to develop novel technologies for early lung cancer detection

Many cancer survivors continue to have poorer health years after completion of treatment

Case Western Reserve wins NCI grant to study genetic determinants of esophageal cancer

UNC professor to co-direct Barrett's Esophagus Translational Research Network projects

Not enough doctors in Australia to follow up on breast cancer cases

Genetic testing for breast and ovarian cancer

Sanofi-aventis sponsors People vs. Cancer initiative

Peptide receptor radiolabeled therapy shows promise against neuroendocrine tumors

NTNU genetic research shows best recipe to limit risk of lifestyle-related diseases

New GE healthymagination initiative aims to improve cancer innovation and care

Spanish research establishes factors associated with tiredness in breast cancer survivors

Web-based tool can improve employment outcomes of breast cancer survivors

Women with BRCA gene mutations at risk of developing cancers at earlier ages

New studies on breast cancer screening, treatment and survival

Studies examine overuse of scans in determining status of prostate cancer

First Edition: September 7, 2011

Combination of blood tests and ROMA algorithm receives FDA clearance to treat ovarian cancer

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Low-cost, portable technique can detect specific proteins in human blood

9/11 firefighters at greater risk of cancer

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News